In Silico Methods for Predicting Drug Toxicity

QSAR Methods.- In
Silico 3D-Modelling of Binding Activities.- Modeling Pharmacokinetics.- Modeling
ADMET.- In Silico Prediction of Chemically-Induced Mutagenicity: How to Use
QSAR Models and Interpret Their Results.- In Silico Methods for Carcinogenicity
Assessment.- VirtualToxLab: Exploring the Toxic Potential of Rejuvenating
Substances Found in Traditional Medicines.- In Silico Model for Developmental
Toxicity: How to Use QSAR Models and Interpret Their Results.- In Silico Models
for Repeated Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect
Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs.- In
Silico Models for Acute Systemic Toxicity.- In Silico Models forHepatotoxicity.-
In Silico Models for Ecotoxicity of Pharmaceuticals.- Use of Read-Across Tools.-
Adverse Outcome Pathways as Tools to Assess Drug-Induced Toxicity.- A Systems
Biology Approach for Identifying Hepatotoxicant Groups Based on Similarity in
Mechanisms of Action and Chemical Structure.- In Silico Study of In Vitro GPCR
Assays by QSAR Modeling.- Taking Advantage of Databases.- QSAR Models at the
United States FDA/NCTR.- A Round Trip from Medicinal Chemistry to Predictive
Toxicology.- The Use of In Silico Models Within a Large Pharmaceutical Company.-
The Consultancy Activity on In Silico Models for Genotoxic Prediction of
Pharmaceutical Impurities.